Global Herceptin Biosimilar Sales Market Report 2024

Report ID: 864170 | Published Date: Jan 2025 | No. of Page: 137 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Herceptin Biosimilar Market Overview
    1.1 Herceptin Biosimilar Product Scope
    1.2 Herceptin Biosimilar Segment by Type
        1.2.1 Global Herceptin Biosimilar Sales by Type (2016 & 2021 & 2027)
        1.2.2 Breast Cancer
        1.2.3 Colorectal Cancer
        1.2.4 Leukemia
        1.2.5 Lymphoma
        1.2.6 Other
    1.3 Herceptin Biosimilar Segment by Application
        1.3.1 Global Herceptin Biosimilar Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Hospital & Clinics
        1.3.3 Oncology Centers
        1.3.4 Other
    1.4 Herceptin Biosimilar Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Herceptin Biosimilar Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Herceptin Biosimilar Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Herceptin Biosimilar Price Trends (2016-2027)

2 Herceptin Biosimilar Estimates and Forecasts by Region
    2.1 Global Herceptin Biosimilar Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Herceptin Biosimilar Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Herceptin Biosimilar Sales Market Share by Region (2016-2021)
        2.2.2 Global Herceptin Biosimilar Revenue Market Share by Region (2016-2021)
    2.3 Global Herceptin Biosimilar Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Herceptin Biosimilar Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Herceptin Biosimilar Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Herceptin Biosimilar Estimates and Projections (2016-2027)
        2.4.2 Europe Herceptin Biosimilar Estimates and Projections (2016-2027)
        2.4.3 China Herceptin Biosimilar Estimates and Projections (2016-2027)
        2.4.4 Japan Herceptin Biosimilar Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Herceptin Biosimilar Estimates and Projections (2016-2027)
        2.4.6 India Herceptin Biosimilar Estimates and Projections (2016-2027)
3 Global Herceptin Biosimilar Competition Landscape by Players
    3.1 Global Top Herceptin Biosimilar Players by Sales (2016-2021)
    3.2 Global Top Herceptin Biosimilar Players by Revenue (2016-2021)
    3.3 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herceptin Biosimilar as of 2020)
    3.4 Global Herceptin Biosimilar Average Price by Company (2016-2021)
    3.5 Manufacturers Herceptin Biosimilar Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Herceptin Biosimilar Market Size by Type
    4.1 Global Herceptin Biosimilar Historic Market Review by Type (2016-2021)
        4.1.1 Global Herceptin Biosimilar Sales Market Share by Type (2016-2021)
        4.1.2 Global Herceptin Biosimilar Revenue Market Share by Type (2016-2021)
        4.1.3 Global Herceptin Biosimilar Price by Type (2016-2021)
    4.2 Global Herceptin Biosimilar Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Herceptin Biosimilar Sales Forecast by Type (2022-2027)
        4.2.2 Global Herceptin Biosimilar Revenue Forecast by Type (2022-2027)
        4.2.3 Global Herceptin Biosimilar Price Forecast by Type (2022-2027)
5 Global Herceptin Biosimilar Market Size by Application
    5.1 Global Herceptin Biosimilar Historic Market Review by Application (2016-2021)
        5.1.1 Global Herceptin Biosimilar Sales Market Share by Application (2016-2021)
        5.1.2 Global Herceptin Biosimilar Revenue Market Share by Application (2016-2021)
        5.1.3 Global Herceptin Biosimilar Price by Application (2016-2021)
    5.2 Global Herceptin Biosimilar Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Herceptin Biosimilar Sales Forecast by Application (2022-2027)
        5.2.2 Global Herceptin Biosimilar Revenue Forecast by Application (2022-2027)
        5.2.3 Global Herceptin Biosimilar Price Forecast by Application (2022-2027)

6 North America Herceptin Biosimilar Market Facts & Figures
    6.1 North America Herceptin Biosimilar Sales by Company
        6.1.1 North America Herceptin Biosimilar Sales by Company (2016-2021)
        6.1.2 North America Herceptin Biosimilar Revenue by Company (2016-2021)
    6.2 North America Herceptin Biosimilar Sales Breakdown by Type
        6.2.1 North America Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        6.2.2 North America Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    6.3 North America Herceptin Biosimilar Sales Breakdown by Application
        6.3.1 North America Herceptin Biosimilar Sales Breakdown by Application (2016-2021)
        6.3.2 North America Herceptin Biosimilar Sales Breakdown by Application (2022-2027)

7 Europe Herceptin Biosimilar Market Facts & Figures
    7.1 Europe Herceptin Biosimilar Sales by Company
        7.1.1 Europe Herceptin Biosimilar Sales by Company (2016-2021)
        7.1.2 Europe Herceptin Biosimilar Revenue by Company (2016-2021)
    7.2 Europe Herceptin Biosimilar Sales Breakdown by Type
        7.2.1 Europe Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    7.3 Europe Herceptin Biosimilar Sales Breakdown by Application
        7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Herceptin Biosimilar Market Facts & Figures
    8.1 China Herceptin Biosimilar Sales by Company
        8.1.1 China Herceptin Biosimilar Sales by Company (2016-2021)
        8.1.2 China Herceptin Biosimilar Revenue by Company (2016-2021)
    8.2 China Herceptin Biosimilar Sales Breakdown by Type
        8.2.1 China Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        8.2.2 China Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    8.3 China Herceptin Biosimilar Sales Breakdown by Application
        8.3.1 China 242 Sales Breakdown by Application (2016-2021)
        8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Herceptin Biosimilar Market Facts & Figures
    9.1 Japan Herceptin Biosimilar Sales by Company
        9.1.1 Japan Herceptin Biosimilar Sales by Company (2016-2021)
        9.1.2 Japan Herceptin Biosimilar Revenue by Company (2016-2021)
    9.2 Japan Herceptin Biosimilar Sales Breakdown by Type
        9.2.1 Japan Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    9.3 Japan Herceptin Biosimilar Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Herceptin Biosimilar Market Facts & Figures
    10.1 Southeast Asia Herceptin Biosimilar Sales by Company
        10.1.1 Southeast Asia Herceptin Biosimilar Sales by Company (2016-2021)
        10.1.2 Southeast Asia Herceptin Biosimilar Revenue by Company (2016-2021)
    10.2 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type
        10.2.1 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Herceptin Biosimilar Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Herceptin Biosimilar Market Facts & Figures
    11.1 India Herceptin Biosimilar Sales by Company
        11.1.1 India Herceptin Biosimilar Sales by Company (2016-2021)
        11.1.2 India Herceptin Biosimilar Revenue by Company (2016-2021)
    11.2 India Herceptin Biosimilar Sales Breakdown by Type
        11.2.1 India Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
        11.2.2 India Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
    11.3 India Herceptin Biosimilar Sales Breakdown by Application
        11.3.1 India Herceptin Biosimilar Sales Breakdown by Application (2016-2021)
        11.3.2 India Herceptin Biosimilar Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Herceptin Biosimilar Business
    12.1 Amgen
        12.1.1 Amgen Corporation Information
        12.1.2 Amgen Business Overview
        12.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Amgen Herceptin Biosimilar Products Offered
        12.1.5 Amgen Recent Development
    12.2 AryoGen Biopharma
        12.2.1 AryoGen Biopharma Corporation Information
        12.2.2 AryoGen Biopharma Business Overview
        12.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 AryoGen Biopharma Herceptin Biosimilar Products Offered
        12.2.5 AryoGen Biopharma Recent Development
    12.3 Biocon
        12.3.1 Biocon Corporation Information
        12.3.2 Biocon Business Overview
        12.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Biocon Herceptin Biosimilar Products Offered
        12.3.5 Biocon Recent Development
    12.4 Celltrion
        12.4.1 Celltrion Corporation Information
        12.4.2 Celltrion Business Overview
        12.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Celltrion Herceptin Biosimilar Products Offered
        12.4.5 Celltrion Recent Development
    12.5 Gedeon Richter
        12.5.1 Gedeon Richter Corporation Information
        12.5.2 Gedeon Richter Business Overview
        12.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
        12.5.5 Gedeon Richter Recent Development
    12.6 Genor Biopharma
        12.6.1 Genor Biopharma Corporation Information
        12.6.2 Genor Biopharma Business Overview
        12.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
        12.6.5 Genor Biopharma Recent Development
    12.7 Mabion
        12.7.1 Mabion Corporation Information
        12.7.2 Mabion Business Overview
        12.7.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Mabion Herceptin Biosimilar Products Offered
        12.7.5 Mabion Recent Development
    12.8 Mylan
        12.8.1 Mylan Corporation Information
        12.8.2 Mylan Business Overview
        12.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Mylan Herceptin Biosimilar Products Offered
        12.8.5 Mylan Recent Development
    12.9 Roche
        12.9.1 Roche Corporation Information
        12.9.2 Roche Business Overview
        12.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Roche Herceptin Biosimilar Products Offered
        12.9.5 Roche Recent Development
    12.10 The Instituto Vital Brazil
        12.10.1 The Instituto Vital Brazil Corporation Information
        12.10.2 The Instituto Vital Brazil Business Overview
        12.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 The Instituto Vital Brazil Herceptin Biosimilar Products Offered
        12.10.5 The Instituto Vital Brazil Recent Development

13 Herceptin Biosimilar Manufacturing Cost Analysis
    13.1 Herceptin Biosimilar Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Herceptin Biosimilar
    13.4 Herceptin Biosimilar Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Herceptin Biosimilar Distributors List
    14.3 Herceptin Biosimilar Customers

15 Market Dynamics
    15.1 Herceptin Biosimilar Market Trends
    15.2 Herceptin Biosimilar Drivers
    15.3 Herceptin Biosimilar Market Challenges
    15.4 Herceptin Biosimilar Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Herceptin Biosimilar Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Herceptin Biosimilar Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Herceptin Biosimilar Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Herceptin Biosimilar Sales (K Units) by Region (2016-2021)
    Table 5. Global Herceptin Biosimilar Sales Market Share by Region (2016-2021)
    Table 6. Global Herceptin Biosimilar Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Herceptin Biosimilar Revenue Share by Region (2016-2021)
    Table 8. Global Herceptin Biosimilar Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Herceptin Biosimilar Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Herceptin Biosimilar Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Herceptin Biosimilar Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Herceptin Biosimilar Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Herceptin Biosimilar Sales Share by Company (2016-2021)
    Table 14. Global Herceptin Biosimilar Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Herceptin Biosimilar Revenue Share by Company (2016-2021)
    Table 16. Global Herceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2020)
    Table 17. Global Herceptin Biosimilar Average Price (USD/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Herceptin Biosimilar Manufacturing Sites and Area Served
    Table 19. Manufacturers Herceptin Biosimilar Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Herceptin Biosimilar Sales (K Units) by Type (2016-2021)
    Table 22. Global Herceptin Biosimilar Sales Share by Type (2016-2021)
    Table 23. Global Herceptin Biosimilar Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Herceptin Biosimilar Price (USD/Unit) by Type (2016-2021)
    Table 25. Global Herceptin Biosimilar Sales Share by Type (2022-2027)
    Table 26. Global Herceptin Biosimilar Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Herceptin Biosimilar Revenue Share by Type (2022-2027)
    Table 28. Global Herceptin Biosimilar Price (USD/Unit) by Type (2022-2027)
    Table 29. Global Herceptin Biosimilar Sales (K Units) by Application (2016-2021) 
    Table 30. Global Herceptin Biosimilar Sales Share by Application (2016-2021)
    Table 31. Global Herceptin Biosimilar Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Herceptin Biosimilar Price (USD/Unit) by Application (2016-2021)
    Table 33. Global Herceptin Biosimilar Sales (K Units) by Application (2022-2027)
    Table 34. Global Herceptin Biosimilar Sales Share by Application (2022-2027)
    Table 35. Global Herceptin Biosimilar Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Herceptin Biosimilar Revenue Share by Application (2022-2027)
    Table 37. Global Herceptin Biosimilar Price (USD/Unit) by Application (2022-2027)
    Table 38. North America Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 39. North America Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 40. North America Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 42. North America Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 43. North America Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 44. North America Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 45. North America Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 46. North America Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 47. North America Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 48. North America Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 49. North America Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 50. Europe Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 51. Europe Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 52. Europe Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 54. Europe Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 56. Europe Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 58. Europe Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 60. Europe Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 62. China Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 63. China Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 64. China Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 66. China Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 67. China Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 68. China Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 69. China Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 70. China Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 71. China Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 72. China Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 73. China Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 74. Japan Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 75. Japan Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 76. Japan Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 78. Japan Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 80. Japan Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 82. Japan Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 84. Japan Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 98. India Herceptin Biosimilar Sales (K Units) by Company (2016-2021)
    Table 99. India Herceptin Biosimilar Sales Market Share by Company (2016-2021)
    Table 100. India Herceptin Biosimilar Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Herceptin Biosimilar Revenue Market Share by Company (2016-2021)
    Table 102. India Herceptin Biosimilar Sales by Type (2016-2021) & (K Units)
    Table 103. India Herceptin Biosimilar Sales Market Share by Type (2016-2021)
    Table 104. India Herceptin Biosimilar Sales by Type (2022-2027) & (K Units)
    Table 105. India Herceptin Biosimilar Sales Market Share by Type (2022-2027)
    Table 106. India Herceptin Biosimilar Sales by Application (2016-2021) & (K Units)
    Table 107. India Herceptin Biosimilar Sales Market Share by Application (2016-2021)
    Table 108. India Herceptin Biosimilar Sales by Application (2022-2027) & (K Units)
    Table 109. India Herceptin Biosimilar Sales Market Share by Application (2022-2027)
    Table 110. Amgen Corporation Information
    Table 111. Amgen Description and Business Overview
    Table 112. Amgen Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. Amgen Herceptin Biosimilar Product
    Table 114. Amgen Recent Development
    Table 115. AryoGen Biopharma Corporation Information
    Table 116. AryoGen Biopharma Description and Business Overview
    Table 117. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. AryoGen Biopharma Herceptin Biosimilar Product
    Table 119. AryoGen Biopharma Recent Development
    Table 120. Biocon Corporation Information
    Table 121. Biocon Description and Business Overview
    Table 122. Biocon Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Biocon Herceptin Biosimilar Product
    Table 124. Biocon Recent Development
    Table 125. Celltrion Corporation Information
    Table 126. Celltrion Description and Business Overview
    Table 127. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Celltrion Herceptin Biosimilar Product
    Table 129. Celltrion Recent Development
    Table 130. Gedeon Richter Corporation Information
    Table 131. Gedeon Richter Description and Business Overview
    Table 132. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. Gedeon Richter Herceptin Biosimilar Product
    Table 134. Gedeon Richter Recent Development
    Table 135. Genor Biopharma Corporation Information
    Table 136. Genor Biopharma Description and Business Overview
    Table 137. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. Genor Biopharma Herceptin Biosimilar Product
    Table 139. Genor Biopharma Recent Development
    Table 140. Mabion Corporation Information
    Table 141. Mabion Description and Business Overview
    Table 142. Mabion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Mabion Herceptin Biosimilar Product
    Table 144. Mabion Recent Development
    Table 145. Mylan Corporation Information
    Table 146. Mylan Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 147. Mylan Description and Business Overview
    Table 148. Mylan Herceptin Biosimilar Product
    Table 149. Mylan Recent Development
    Table 150. Roche Corporation Information
    Table 151. Roche Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 152. Roche Description and Business Overview
    Table 153. Roche Herceptin Biosimilar Product
    Table 154. Roche Recent Development
    Table 155. The Instituto Vital Brazil Corporation Information
    Table 156. The Instituto Vital Brazil Description and Business Overview
    Table 157. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. The Instituto Vital Brazil Herceptin Biosimilar Product
    Table 159. The Instituto Vital Brazil Recent Development
    Table 160. Production Base and Market Concentration Rate of Raw Material
    Table 161. Key Suppliers of Raw Materials
    Table 162. Herceptin Biosimilar Distributors List
    Table 163. Herceptin Biosimilar Customers List
    Table 164. Herceptin Biosimilar Market Trends
    Table 165. Herceptin Biosimilar Market Drivers
    Table 166. Herceptin Biosimilar Market Challenges
    Table 167. Herceptin Biosimilar Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Herceptin Biosimilar Product Picture
    Figure 2. Global Herceptin Biosimilar Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Herceptin Biosimilar Sales Market Share by Application in 2021 & 2027
    Figure 6. Hospital & Clinics Examples
    Figure 7. Oncology Centers Examples
    Figure 8. Other Examples
    Figure 9. Global Herceptin Biosimilar Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Herceptin Biosimilar Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Herceptin Biosimilar Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Herceptin Biosimilar Price Trends Growth Rate (2016-2027) (USD/Unit)
    Figure 13. Global Herceptin Biosimilar Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Herceptin Biosimilar Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Herceptin Biosimilar Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Herceptin Biosimilar Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Herceptin Biosimilar Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Herceptin Biosimilar Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Herceptin Biosimilar Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Herceptin Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Herceptin Biosimilar Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Herceptin Biosimilar Players Market Share by Revenue in Herceptin Biosimilar: 2016 & 2020
    Figure 28. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Herceptin Biosimilar Revenue Share by Type (2016-2021)
    Figure 30. Global Herceptin Biosimilar Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Herceptin Biosimilar Revenue Share by Application (2016-2021)
    Figure 32. Global Herceptin Biosimilar Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 34. North America Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 35. Europe Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 36. Europe Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 37. China Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 38. China Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 39. Japan Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 40. Japan Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 43. India Herceptin Biosimilar Sales Market Share by Type in 2020
    Figure 44. India Herceptin Biosimilar Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Herceptin Biosimilar 
    Figure 47. Manufacturing Process Analysis of Herceptin Biosimilar
    Figure 48. Herceptin Biosimilar Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil
Frequently Asked Questions
Herceptin Biosimilar report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Herceptin Biosimilar report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Herceptin Biosimilar report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Atmospheric Furnace

Atmospheric furnaces are also stated as controlled atmosphere furnace which is used to accommodat ... Read More